BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 28011809)

  • 1. Safety and efficacy of tocotrienol supplementation for bone health in postmenopausal women: protocol for a dose-response double-blinded placebo-controlled randomised trial.
    Shen CL; Mo H; Yang S; Wang S; Felton CK; Tomison MD; Soelaiman IN
    BMJ Open; 2016 Dec; 6(12):e012572. PubMed ID: 28011809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tocotrienol supplementation suppressed bone resorption and oxidative stress in postmenopausal osteopenic women: a 12-week randomized double-blinded placebo-controlled trial.
    Shen CL; Yang S; Tomison MD; Romero AW; Felton CK; Mo H
    Osteoporos Int; 2018 Apr; 29(4):881-891. PubMed ID: 29330573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Actions of annatto-extracted tocotrienol supplementation on obese postmenopausal women: study protocol for a double-blinded, placebo-controlled, randomised trial.
    Aryaie A; Tinsley G; Lee J; Watkins BA; Moore L; Alhaj-Saleh A; Shankar K; Wood SR; Wang R; Shen CL
    BMJ Open; 2020 Mar; 10(3):e034338. PubMed ID: 32152169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 12-week evaluation of annatto tocotrienol supplementation for postmenopausal women: safety, quality of life, body composition, physical activity, and nutrient intake.
    Shen CL; Wang S; Yang S; Tomison MD; Abbasi M; Hao L; Scott S; Khan MS; Romero AW; Felton CK; Mo H
    BMC Complement Altern Med; 2018 Jun; 18(1):198. PubMed ID: 29954374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Green tea polyphenols and Tai Chi for bone health: designing a placebo-controlled randomized trial.
    Shen CL; Chyu MC; Yeh JK; Felton CK; Xu KT; Pence BC; Wang JS
    BMC Musculoskelet Disord; 2009 Sep; 10():110. PubMed ID: 19732445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a Multispecies Probiotic Supplement on Bone Health in Osteopenic Postmenopausal Women: A Randomized, Double-blind, Controlled Trial.
    Jafarnejad S; Djafarian K; Fazeli MR; Yekaninejad MS; Rostamian A; Keshavarz SA
    J Am Coll Nutr; 2017; 36(7):497-506. PubMed ID: 28628374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A calcium-collagen chelate dietary supplement attenuates bone loss in postmenopausal women with osteopenia: a randomized controlled trial.
    Elam ML; Johnson SA; Hooshmand S; Feresin RG; Payton ME; Gu J; Arjmandi BH
    J Med Food; 2015 Mar; 18(3):324-31. PubMed ID: 25314004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tocotrienol supplementation in postmenopausal osteoporosis: evidence from a laboratory study.
    Muhammad N; Luke DA; Shuid AN; Mohamed N; Soelaiman IN
    Clinics (Sao Paulo); 2013 Oct; 68(10):1338-43. PubMed ID: 24212841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and safety of herbal medicine BHH10 in postmenopausal women with osteoporosis: study protocol for a phase II, multicenter, randomized, double-blinded, placebo-controlled clinical trial.
    Cho Y; Lee S; Kim J; Kang JW; Baek YH; Seo BK; Lee JD
    Trials; 2018 Sep; 19(1):482. PubMed ID: 30201024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral daily ibandronate prevents bone loss in early postmenopausal women without osteoporosis.
    McClung MR; Wasnich RD; Recker R; Cauley JA; Chesnut CH; Ensrud KE; Burdeska A; Mills T;
    J Bone Miner Res; 2004 Jan; 19(1):11-8. PubMed ID: 14753731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of potassium citrate supplementation or increased fruit and vegetable intake on bone metabolism in healthy postmenopausal women: a randomized controlled trial.
    Macdonald HM; Black AJ; Aucott L; Duthie G; Duthie S; Sandison R; Hardcastle AC; Lanham New SA; Fraser WD; Reid DM
    Am J Clin Nutr; 2008 Aug; 88(2):465-74. PubMed ID: 18689384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of antiresorptive bone medication on the effect of high-intensity resistance and impact training on osteoporotic fracture risk in postmenopausal women with low bone mass: protocol for the MEDEX-OP randomised controlled trial.
    Fischbacher M; Weeks BK; Beck BR
    BMJ Open; 2019 Sep; 9(9):e029895. PubMed ID: 31492784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trial.
    Cheung AM; Tile L; Cardew S; Pruthi S; Robbins J; Tomlinson G; Kapral MK; Khosla S; Majumdar S; Erlandson M; Scher J; Hu H; Demaras A; Lickley L; Bordeleau L; Elser C; Ingle J; Richardson H; Goss PE
    Lancet Oncol; 2012 Mar; 13(3):275-84. PubMed ID: 22318095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moxibustion as adjuvant therapy for preventing bone loss in postmenopausal women: protocol for a randomised controlled trial.
    Lu L; Wen Q; Zhang X; Lv J; Zhang L; Liu L; Yu X; Li N
    BMJ Open; 2022 Dec; 12(12):e062677. PubMed ID: 36523246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of osteoporosis and uterine effects in postmenopausal women taking raloxifene for 5 years.
    Jolly EE; Bjarnason NH; Neven P; Plouffe L; Johnston CC; Watts SD; Arnaud CD; Mason TM; Crans G; Akers R; Draper MW
    Menopause; 2003; 10(4):337-44. PubMed ID: 12851517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of odanacatib on BMD and safety in the treatment of osteoporosis in postmenopausal women previously treated with alendronate: a randomized placebo-controlled trial.
    Bonnick S; De Villiers T; Odio A; Palacios S; Chapurlat R; DaSilva C; Scott BB; Le Bailly De Tilleghem C; Leung AT; Gurner D
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4727-35. PubMed ID: 24064689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of a novel salmon calcitonin (sCT) technology-based oral formulation in healthy postmenopausal women: acute and 3-month effects on biomarkers of bone turnover.
    Tankó LB; Bagger YZ; Alexandersen P; Devogelaer JP; Reginster JY; Chick R; Olson M; Benmammar H; Mindeholm L; Azria M; Christiansen C
    J Bone Miner Res; 2004 Sep; 19(9):1531-8. PubMed ID: 15312255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Vitamin E Supplement on Bone Turnover Markers in Postmenopausal Osteopenic Women: A Double-Blind, Randomized, Placebo-Controlled Trial.
    Vallibhakara SA; Nakpalat K; Sophonsritsuk A; Tantitham C; Vallibhakara O
    Nutrients; 2021 Nov; 13(12):. PubMed ID: 34959779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of two doses of dried plum on bone density and bone biomarkers in osteopenic postmenopausal women: a randomized, controlled trial.
    Hooshmand S; Kern M; Metti D; Shamloufard P; Chai SC; Johnson SA; Payton ME; Arjmandi BH
    Osteoporos Int; 2016 Jul; 27(7):2271-2279. PubMed ID: 26902092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating the causal effect of milk powder supplementation on bone mineral density: a randomized controlled trial with both non-compliance and loss to follow-up.
    Chen Y; Zhang Q; Wang Y; Xiao Y; Fu R; Bao H; Liu M
    Eur J Clin Nutr; 2015 Jul; 69(7):824-30. PubMed ID: 25626413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.